InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-16 · accession 0001415889-24-004474 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-20 2024-02-16 HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 +37.9K 680.2K +6% $0
DM 2024-02-20 2024-02-16 HALO Torley Helen Pres AND CEO, Dir F - Tax $36.10 -20.4K 676.7K -3% -$735.1K
DM 2024-02-20 2024-02-16 HALO Torley Helen Pres AND CEO, Dir M - OptEx $0.00 -37.9K 50.6K -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-16 M A 16,875 $0.00 685,814 D — —
2 Common Common Stock 2024-02-16 F D 11,292 $36.10 668,939 D — — (F1) The reported disposition of 11,292 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
3 Common Common Stock 2024-02-16 M A 21,009 $0.00 680,231 D — —
4 Common Common Stock 2024-02-16 F D 9,070 $36.10 676,744 D — — (F2) The reported disposition of 9,070 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
5 Derivative Restricted Stock Units 2024-02-16 M D 21,009 $0.00 42,018 D $0.00 · — to — 21,009 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2024-02-16 M D 16,875 $0.00 50,624 D $0.00 · — to — 16,875 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.